Evidence map›Paper›PMID 36147747›Full record

ArticleProceedings of SPIE--the International Society for Optical Engineering

Predicting 3D dose distribution with scale attention network for prostate cancer radiotherapy.

Saba Adabi, Tzu-Chi Tsen, Yading Yuan

Open access · greenAbstract read
In one paragraph

Article in Proceedings of SPIE--the International Society for Optical Engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Saba AdabiDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, NY, NYC, USA, 10029.
Tzu-Chi TsenDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, NY, NYC, USA, 10029.
Yading YuanDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, NY, NYC, USA, 10029.
Icahn School of Medicine at Mount Sinai · US

Funding

MSHS Translational Science HubUL1TR001433 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WRIGHT, ROSALIND J · 2015 to 2019
$26.6M
A Fully Decentralized Federated Learning Framework for Automated Image Segmentation in Cancer RadiotherapyR21EB030209 · NIBIB · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI YUAN, YADING · 2021 to 2021
$653k
NCATS NIH HHS UL1 TR001433NIBIB NIH HHS R21 EB030209
6 · The paper itself

Abstract

The growing demand for radiation therapy to treat cancer has been directed to focus on improving treatment planning flow for patients. Accurate dose prediction, therefore, plays a prominent role in this regard. In this study, we propose a framework based on our newly developed scale attention networks (SA-Net) to attain voxel-wise dose prediction. Our network 's dynamic scale attention model incorporates low-level details with high-level semantics from feature maps at different scales. To achieve more accurate results, we used distance data between each local voxel and the organ surfaces instead of binary masks of organs at risk as well as CT image as input of the network. The proposed method is tested on prostate cancer treated with Volumetric Modulated Arc Therapy (VMAT), where the model was training with 120 cases and tested on 20 cases. The average dose difference between the predicted dose and the clinical planned dose was 0.94 Gy, which is equivalent to 2.1% as compared to the prescription dose of 45 Gy. We also compared the performance of SA-Net dose prediction framework with different input format, the signed distance map vs. binary mask and showed the signed distance map was a better format as input to the model training. These findings show that our deep learning-based strategy of dose prediction is effectively feasible for automating the treatment planning in prostate cancer radiography.

Indexed as

Deep learningdose predictionprostate radiotherapyscale attention

Identifiers

PMID36147747
PMCPMC9491520
OpenAlexW4220732941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.